Trimethylamine-N-Oxide Pathway: A Potential Target for the Treatment of MAFLD

Trimethylamine-N-oxide (TMAO) is a molecular metabolite derived from the gut flora, which has recently emerged as a candidate risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD). TMAO is mainly derived from gut, where the gut microbiota converts TMA precursors into TMA, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xun, Hong, Jia, Wang, Yao, Pei, Maohua, Wang, Luwen, Gong, Zuojiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517136/
https://www.ncbi.nlm.nih.gov/pubmed/34660695
http://dx.doi.org/10.3389/fmolb.2021.733507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517136/
https://www.ncbi.nlm.nih.gov/pubmed/34660695
http://dx.doi.org/10.3389/fmolb.2021.733507

Ejemplares similares